Clinical trial
Ototoxicity of Artemether / Lumefantrine (Coartem) and Other Antimalarials
NCT00451139 · Jimma University, Other · Completed
Key facts
| NCT number | NCT00451139 |
|---|---|
| Title | Ototoxicity of Artemether / Lumefantrine (Coartem) and Other Antimalarials |
| Lead sponsor | Jimma University, Other |
| Collaborators | Ludwig-Maximilians - University of Munich |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Malaria |
| Intervention type | Drug |
| Interventions | artemether/lumefantrine, quinine, atovaquone/proguanil |
| First posted | Mar 23, 2007 |
| Last update posted | Mar 23, 2007 |
| Countries | Ethiopia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: